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Abstract. Identifying measurable genetic indicators (or biomarkers) of
a specific condition of a biological system is a key element of precision
medicine. Indeed it allows to tailor diagnostic, prognostic and treatment
choice to individual characteristics of a patient. In machine learning
terms, biomarker discovery can be framed as a feature selection problem
on whole-genome data sets. However, classical feature selection methods
are usually underpowered to process these data sets, which contain or-
ders of magnitude more features than samples. This can be addressed
by making the assumption that genetic features that are linked on a
biological network are more likely to work jointly towards explaining
the phenotype of interest. We review here three families of methods for
feature selection that integrate prior knowledge in the form of networks.
Keywords: Biological Networks, Structured Sparsity, Feature Selection,
Biomarker Discovery
1 Introduction and Motivation
Therapeutic development today is largely based on large-scale clinical trials and
the average responses of thousands of people. However, a large number of medical
conditions have no satisfactory treatment, and when treatment is available, many
patients either do not respond or experience unacceptable side effects [1]. This is
explained both by variations in environment and life styles between individuals,
and by their genetic differences. As a consequence, precision medicine, which
aims at tailoring preventive and curative treatments to patients based on their
individual characteristics, is gaining considerable momentum. At its core, it relies
on identifying features, genetic or otherwise, that correlate with risk, prognosis
or response to treatment. Here we are interested in the identification, from large
whole-genome dataset, of genetic features associated with a trait of interest. Such
features, which can be used to aid diagnostic, prognostic or treatment choice,
are often refered to as biomarkers.
Biomarker discovery, which can be framed as a feature selection problem,
depends on collecting considerable amounts of molecular data for large numbers
of individuals. This is being enabled by thriving developments in genome se-
quencing and other high-throughput experimental technologies, thanks to which
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it is now possible to accumulate tens of millions of genomic descriptors (such as
single-nucleotide polymorphisms or copy number variations of the DNA, gene
expression levels, protein activities, or methylation status) for thousands of in-
dividuals [2]. However, these technological advances have not yet been accom-
panied by similarly powerful improvements in the methods used to analyze the
resulting data [3].
One of the major issues we are facing is that feature selection methods suffer
from a small sample size problem: they are statistically underpowered when the
dimensionality of the data (the number of biomarkers to investigate) is orders
of magnitude larger than the number of samples available. This is one of the
reasons behind the relative failure of genome-wide association studies to explain
most of the genetic heredity of many complex traits [4].
This problem can be addressed by using prior biological knowledge, which
reduces the space of possible solutions and helps capturing relevant information
in a statistically sound fashion. When a human expert is available, this is a typ-
ical application case for interactive machine learning [5], where a domain expert
drives a heuristic procedure to reduce the complexity of the search space. This
type of “doctor-in-the-loop” approach has recently been successfully applied in
the clinic[6]. However, such analyses are currently restricted to relatively small
numbers of a variables (61 in the example cited above) and it is not always pos-
sible to involve an expert directly. Hence, we will focus on using prior knowledge
compiled in databases.
Because genes do not work in isolation, but rather cooperate through their
interaction (physical, regulatory, or through co-expression) in cellular pathways
and molecular networks, this prior biological knowledge is often available in a
structured way, and in particular under the form of networks. Examples include
the STRING database [7], which contains physical and functional interactions,
both computationally predicted and experimentally confirmed, for over 2 000
organisms, or BioGRID [8], which includes interactions, chemical associations,
and post-translational modifications from the literature. In addition, systems
biologists are building specialized networks, focused on the pathways involved
in a particular disease. One example of such networks is ACSN [9], a compre-
hensive map of molecular mechanisms implicated in cancer. These gene-gene
interaction networks can be used to define networks between genomic descrip-
tors, by mapping these descriptors to genes, using for instance in the case of
SNPs a fixed-size window over the genetic sequence, and connecting together all
descriptors mapped to the same gene, and all descriptors mapped to either of
two interacting genes [10]. We will here make the assumption that genetic fea-
tures that are linked on such a network are more likely to work jointly towards
explaining the phenotype of interest, and that such effects would otherwise be
missed when considering them individually.
This chapter focuses on methods for feature selection that integrate prior
knowledge as networks. Compared to pathway-based approaches, which assess
whether predefined sets of genes are associated with a given trait, network-based
approaches introduce flexibility in the definition of associated gene sets. We will
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review three families of approaches, namely post-hoc analyses, regularized re-
gression and penalized relevance, before presenting their multi-task versions and
discussing open problems and challenges in network-guided biomarker discovery.
2 Glossary and Key Terms
Feature selection: In machine learning, feature selection [11] aims at identifying
the most important features in a data set and discarding those that are irrele-
vant or redundant. This framework is clearly well-suited to the identification of
biologically relevant features.
Sparsity: A model is said to be sparse when it only contains a small number of
non-zero parameters, with respect to the number of features that can be mea-
sured on the objects this model represents [12]. This is closely related to feature
selection: if these parameters are weights on the features of the model, then only
the few features with non-zero weights actually enter the model, and can be
considered selected.
Genome-Wide Association Study (GWAS): GWAS are one of the prevalent tools
for detecting genetic variants associated with a phenotype. They consist in col-
lecting, for a large cohort of individuals, the alleles they exhibit across of the
order of 250, 000 to several millions of Single Nucleotide Polymorphisms (SNPs),
that is to say, individual locations across the genome where nucleotide variations
can occur. The individuals are also phenotyped, meaning that a trait of interest
(which can be binary, such as disease status, or continuous, such as age of onset)
is recorded for each of them. Statistical tests are then run to detect associations
between the SNPs and the phenotype. A recent overview of the classical GWAS
techniques can be found in [13].
Graph / Network: A graph (network) (V, E) consists of a set of vertices (nodes)
V and a set of edges (links) E made of pairs of vertices. If the pair is ordered,
then the edge is directed; otherwise, it is undirected. A graph with no directed
edge is called undirected; unless otherwise specified, this is the type of graph we
consider here. We use the notation i ∼ j to denote that vertex i and vertex j
form an edge in the graph considered.
Adjacency matrix: Given a graph (V, E), its adjacency matrix is a square matrix
W ∈ Rd×d, where d = |V| is the number of vertices, and Wij 6= 0 if and only if
there is an edge between the i-th and the j-th elements of V. Wij ∈ R represents
the weight of edge (i, j). If all non-zero entries of W are equal to 1, the graph is
said to be unweighted.
Network module: Given a graph G = (V, E), a graph G′ = (V ′, E ′) is said to be
a subgraph of G if and only if V ′ is a subset of V and E ′ is a subset of E . In
systems biology, the term “network module” refers to a subgraph of a biological
network whose nodes work together to achieve a specific function. Examples of
modules include transcriptional modules, which are sets of co-regulated genes
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that share a common function, or signaling pathways, that is to say chains of
interacting proteins that propagate a signal through the cell. In the context of
biomarker discovery, we are interested in finding modules of a given biological
network that are associated with the phenotype under study.
Graph Laplacian: Given a graph G of adjacency matrix W ∈ Rd×d, the Lapla-
cian [14] of G is defined as L := D−W , where D is a d×d diagonal matrix with
diagonal entries Dii =
∑d
j=1Wij . The graph Laplacian is analog to the Lapla-
cian operator in multivariable calculus, and similarly measures to what extent a
graph differs at one vertex from its values at nearby vertices. Given a function
f : V 7→ R, f>Lf quantifies how “smoothly” f varies over the graph [15].
Submodularity: Given a set V, a function Φ : 2V → R is said to be submodular
if for any S, T ⊆ V, Φ(S) + φ(T ) ≥ Φ(S ∪ T ) + Φ(S ∩ T ). This property is
also referred to as that of diminishing returns. Given a graph G and its adja-
cency matrix W , an example of submodular function is the function Φ : S 7→∑
p∈S
∑
q/∈SWpq. In the case of equality, i.e. Φ(S)+φ(T ) = Φ(S ∪T )+Φ(S ∩T )
for any S, T ⊆ V, Φ is said to be modular. In this case, the value of Φ over a set
is equal to the sum of its values over items of that set. The cardinality function
Φ : S 7→ |S| is a simple example of a modular function. Submodular functions
play an important role in optimization [16] and machine learning [17].
3 State of the Art
3.1 Network-based post-analysis of association studies
We start by describing methods that have been developed for the network-based
analysis of GWAS outcomes; these methods can easily be extended to other
type of biomarkers. These approaches start from a classical, single-SNP GWAS,
in which the association of each SNP with the phenotype is evaluated thanks to a
statistical test. This makes it possible to leverage state-of-the-art statistical tests
that, for example, account for sample relatedness [18], address issues related to
correlation between markers (linkage disequilibrium) [19], or are tailored to the
discovery of rare variants [20]. In addition, they can easily be applied without
access to raw data, only on the basis of published summary statistics. Their goal
is to find modules of a given gene-gene network that concentrate more small
p-values than would be expected by chance.
The first step is to map all SNPs from the dataset to genes, and to summarize
the p-values of all SNPs mapped to a given gene as a unique gene p-value. This
summary can be based for example on the minimum, maximum, or average p-
value. A popular alternative consists in using VEGAS, which accounts for linkage
disequilibrium between markers [21].
Several search methods have been proposed to find modules of significantly
associated genes from such data. In dmGWAS [22], the authors use a dense
module searching approach [23] to identify modules that locally maximize the
proportion of low p-value genes. This search algorithm is greedy. It considers each
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gene in the network as a starting seed, from which it grows modules by adding
neighboring genes to the set as long as adding them increases the module’s score
by a given factor.
An alternative approach, first proposed in [24] and refined in PINBPA [25], relies
on a simulated annealing search called JActiveModule and first proposed for the
discovery of regulatory pathways in protein-protein interaction networks [26].
Finally, GrandPrixFixe [27] uses a genetic algorithm for its search strategy.
Limitations Because exact searches are prohibitively expensive in terms of calcu-
lations, these approaches rely on heuristic searches that do not guarantee that the
top-scoring module is found. Let us note however that any highly scoring module
that is detected with such an approach is bound to be, if not biologically, at least
statistically interesting. Methods exist to identify top-scoring sub-networks ex-
actly, but they are too computationally intensive to have been applied to GWAS
at this point [28]. An other way to mitigate this issue is to predefine potential
modules of interest [29], but this strongly limits the flexibility offered by the use
of networks rather than of predefined gene sets. Finally, these computational
issues limit their application to networks defined over genes rather than directly
over biomarkers.
More importantly, such methods rely on single-locus association studies, and are
hence unsuited to detect interacting effects of joint loci. The failure to account
for such intearcting effects is advanced as one of the main reasons why classical
GWAS often does not explain much of the heritability of complex traits [30,4].
3.2 Regularized linear regression
So-called embedded approaches for feature selection [11] offer a way to detect
combinations of variants that are associated with a phenotype. Indeed, they learn
which features (biomarkers here) contribute best to the accuracy of a machine
learning model (a classifier in the case of case/control studies, or a regressor in
the case of a quantitative phenotype) while it is being built.
Regularization Within this framework, the leading example is that of linear
regression [31]. Let us assume the available data is described as (X,y) ∈ Rn×m×
Rn, that is to say as n samples over a m biomarkers (X), together with their
phenotypes (y). A linear regression model assumes that the phenotype can be
explained as a linear function of the biomarkers:
yi =
m∑
p=1
Xipβp + i, (1)
where the regression weights β1, . . . , βm are unknown parameters and i is an
error term. Note that we can equally assume that the mean of y is 0, or that
the first of the m biomarkers is a mock feature of all ones that will serve to
estimate the bias of the model. The least-squares methods provides estimates
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of β1, . . . , βm by minimizing the least-square objective function (or data-fitting
term) given in matrix form by Eq.(2):
arg min
β∈Rm
||Xβ − y||22 . (2)
When m  n, as it is the case in most genome-wide biomarker discovery
datasets, Eq.(2) has an infinite set of solutions. In order to regularize the estima-
tion procedure, one can add to the least-square objective function a penalty term,
or regularization term, that will force the regression weights to respect certain
constraints. A very popular regularizer is the l1-norm of β, ||β||1 =
∑m
p=1 |βp|,
which has the effect of shrinking the βp coefficients and setting a large number
of them to zero, hence achieving feature selection: the features with zero weights
do not enter the model and can hence be rejected. This results in the lasso [31],
which estimates the regression weights by solving Eq.(3). The reason for using
the l1-norm, rather than the l0-norm which counts the number of variables that
enter the model and hence directly enforces sparsity, is that with the l0-norm
the resulting objective function would be non-convex, making its minimization
very challenging computationally.
arg min
β∈Rm
||Xβ − y||22 + λ ||β||1 . (3)
Here, λ ∈ R+ is a parameter which controls the balance between the relevance
and the regularization terms.
Many other regularizers have been proposed, to satisfy a variety of constraints
on the regression weights, and have led to many contributions for the analysis
of GWAS data [32,33,34,35,36].
Network regularizers In particular, it is possible to design regularizers that force
the features that are assigned non-zero weights to follow a given underlying
structure [37,38]. In the context of network-guided biomarker discovery, we will
focus on regularizers Ω(β) that penalize solutions in which the selected features
are not connected over a given network.
We are now assuming that we have access to a biological network over the
biomarkers of interest. Such a network can usually be built from a gene interac-
tion network [10].
A first example of such approaches is the Overlapping Group Lasso [39].
Supposing that the m markers are grouped into r groups {G1, G2, . . . , Gr}, which
can overlap, we denote by VG the set of r-tuples of vector v = (vu)u=1,···r such
that vu is non-zero only on features belonging to group u. The Overlapping
Group Lasso penalty, defined by Eq.(4), induces the choice of weight vectors β
that can be decomposed in r weight vectors v = (vu)u=1,···r such that some of
the vu are equal to zero. This limits the non-zero weights to only some of the
groups. If each network edge defines a group of two biomarkers, then this method
can be applied to network-guided biomarker discovery, where it will encourage
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the selection of biomarkers belonging to the same group, i.e linked by an edge.
Ωogl(β) = infv∈VG :
∑r
u=1 vu=β
r∑
u=1
||vu||2 . (4)
Another way to smooth regression weights along the edges of a predefined
network, while enforcing sparsity, is a variant of the Generalized Fused Lasso [40].
The corresponding penatly is given by Eq.(5). The resulting optimization prob-
lem is typically solved using proximal methods such as the fast iterative shrinkage-
thresholding algorithm (FISTA) [41]. While it has not been applied to biomarker
discovery to the best of our knowledge, [42] successfully applied this approach
to Alzheimer’s disease diagnostic from brain images.
Ωgfl(β) =
∑
p∼q
|βp − βq|+ η ||β||1 . (5)
Alternatively, based on work on regularization operators by Smola and Kon-
dor [15], Grace [43,44] uses a penalty based on the graph Laplacian L of the
biological network, which encourages the coefficients β to be smooth on the
graph structure. This regularizer is given by Eq.(6), and yields a special case
of the recently proposed Generalized Elastic Net [45]. It penalizes coefficient
vectors β that vary a lot over nodes that are linked in the network. The cor-
responding optimization problem can be solved through a coordinate descent
algorithm [46]. Grace was applied to gene-gene networks, but can theoretically
be extended to other types of networks of biomarkers; the aGrace variant allows
connected features to have effects of opposite directions.
Ωgrace(β) = β
>Lβ =
∑
p,q
Wpq(βp − βq)2 (6)
These approaches are rather sensitive to the quality of the network they use,
and might suffer from bias due to graph misspecification. GOSCAR [47] was
proposed to address this issue, and replaces the term |βp − βq| in Eq.(5) with
a non-convex penalty: max (|βp|, |βq|) = 12 (|βp + βq|+ |βp − βq|). The authors
solve the resulting optimization problem using the alternating direction method
of multipliers (ADMM) [48,49].
Finally, while the previous approaches require to build a network over biomark-
ers, the Graph-Guided Group Lasso [50] encourages genes connected on the
network to be selected in and out of the model together (graph penalty), and
biomarkers attached to a given gene to be either selected together or not at all
(group penalty). Supposing that the m biomarkers are grouped into r mutually
exclusive genes {G1, G2, . . . , Gr}, and calling βGu the coefficient vector β re-
stricted to its entries in Gu, the Graph-Guided Group Lasso penalty is given by
Eq.(7). As Grace’s, this optimization problem can be solved with a coordinate
descent algorithm.
Ωgggl(β) =
r∑
u=1
√
|Gu| ||βGu ||2 + η1 ||β||1 + η2
1
2
∑
p∈Gu,q∈Gv
Gu∼Gv
Wuv(βp − βq)2. (7)
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Limitations In practice, we found that the computational burden was a severe
limitation to applying the Overlapping Group Lasso and Grace to the analysis of
more than a hundred thousand markers [10]. On a similar note, the experiments
presented in [47] used at most 8, 000 genes; the graph-guided group lasso [50]
used 1, 000 SNPs only; and the work in [42] used 3, 000 voxels to describe brain
images. It is therefore unclear whether these methods can scale up to several
hundreds of thousands of markers.
While these computational issues might be addressed by using more powerful
solvers or parallel versions of the algorithms, these regularized linear regression
approaches also suffer from their inability to guarantee their stability as feature
selection procedures, meaning their ability to retain the same features upon mi-
nor perturbations of the data. These algorithms are typically highly unstable,
often yielding widely different results for different sets of samples relating to the
same phenotype [51]. There is hope that the use of structural regularizers, such
as those we defined above, can address this phenomenon by helping the selection
of “true” features, but ranking features based on t-test scores often still yields
the most stable selection in practice [52,53].
Finally, it is interesting to note that biomarkers are often represented as cate-
gorical variables (such as the presence or absence of a mutation, or the number
of minor alleles observed in the case of SNPs). Applying linear (or logistic) re-
gressions in this context, although not entirely meaningless, can be considered
an unsatisfying choice.
3.3 Penalized relevance
Let us assume data is described over a set V of m features. The penalized rele-
vance framework proposes to carry out feature selection by identifying the subset
S of V that maximizes the sum of a data-driven relevance function and a domain-
driven regularizer.
The relevance function R : 2V → R quantifies the importance of a set of
features with respect to the task under study. It can be derived from a measure
of correlation, or a statistical test of association between groups of features and
a phenotype.
Our objective is to find the set of features S ⊆ V that maximizes R under
structural constraints, which we model, as previously, by means of a regularizer
Φ : 2V → R, which promotes sparsity patterns that are compatible with a priori
knowledge about the feature space. A simple example of regularizer computes
the cardinality of the selected set. More complex regularizers can be defined to
enforce a specific structure on S, and in particular a network structure [10]. We
hence want to solve the following problem:
arg max
S⊆V
R(S)− λΦ(S). (8)
Here again, λ ∈ R+ is a parameter which controls the balance between the
relevance and the regularization terms.
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This formulation is close to that of the regularized linear regression presented
in Section 3.2. However, Lasso-like approaches focus on the minimization of an
empirical risk (or prediction error), while the penalized relevance framework
shifts the emphasis to the maximization of feature importance with respect to
the question under study. As with the approaches presented in Section 3.1, this
formulation makes it possible to leverage a large body of work from statistical
genetics to define relevance based on appropriate statistical tests. Moreover,
in this framework, optimization is done directly over the power set of V (also
noted as 2V), rather than over Rm. This presents the conceptual advantage of
yielding sparsity formulations that can be optimized without resorting to convex
relaxation, and offers better computational efficiency in very high dimension.
When relying on linear models, relevance functions are modular, meaning
that the relevance of a set of biomarkers is computed as the sum of the rel-
evances of the individual biomarkers in this set. Moreover, a number of sub-
modular, structure-enforcing regularizers can be derived from sparsity-inducing
norms [54]. Among them, the Laplacian-based graph regularizer, which encour-
ages the selected features to be connected on a predefined graph defined by its
adjacency matrix W , is very similar to Ωgrace in Eq.(6). It is given by
ΦLaplacian : S 7→
∑
p∈S
∑
q/∈S
Wpq. (9)
The sum of submodular functions is submodular, hence if R is modular and
Φ submodular, solving Eq.(8) becomes a submodular minimization problem and
can be solved in polynomial time. Unfortunately, algorithms to minimize arbi-
trary submodular functions are slow (O(m5c + m6) where c is the cost of one
function evaluation [55]). However, faster algorithms exist for specific classes of
submodular functions. In particular, graph cut functions can be minimized much
more efficiently in practice with maximum flow approaches [56], a particularity
that has long been exploited in the context of energy minimization in computer
vision [57].
This property can be exploited in the specific case of penalized relevance
implemented in SConES [10], where R is defined by linear SKAT [58] and Φ
by the sum of a cardinality constraint η|S| and the Laplacian-based regularizer
ΦLaplacian defined above. SConES solves the optimization problem given by
Eq.(10):
arg max
S⊆V
∑
p∈S
R({p})− η|S| − λ
∑
p∈S
∑
q/∈S
Wpq. (10)
In this case, the submodular minimization problem can be cast as a graph-cut
problem and solved very efficiently. Figure 1 shows the transformed s/t-graph
for which finding a minimum cut is equivalent to solving Eq.(10). This approach
is available as a Matlab implementation1 as well as part of the sfan Python
package2.
1 https://github.com/chagaz/scones
2 https://github.com/chagaz/sfan
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Fig. 1. This figure, taken from [10], shows a graph for which finding the minimum cut
is equivalent to maximizing the objective function in Eq.(10). cp denotes the relevance
of biomarker p, and Wpq is the weight of the edge connecting biomarker p to biomarker
q in the given network.
Limitations An important aspect of both regularized regression and penalized
relevance is the parameters (such as λ or η) that control the trade-off between
the different terms and regularizers. While they afford these methods their flexi-
bility, one needs to come up with appropriate ways to set them. This is typically
done in an internal cross-validation setting, in which one explores several pos-
sible values for each of the parameters, and choose those leading to the best
performance according to a given criterion. In biomarker discovery, this crite-
rion can either be the predictivity of the selected biomarkers in a given model,
or their stability [59]. Finding a good balance between both aspects is difficult,
as approaches that either select all or none of the features will have high sta-
bility but poor predictivity – and little interest. In addition, exploring multiple
parameter values increases the computational cost of these approaches.
While SConES is computationally more efficient than the regularized regression
approaches, it also suffers from the limitation of relying on an additive model, in
which the final phenotype is a function of a linear combination of the individual
effects of each biomarker. Biology, however, is highly non-linear, and we expect
the effect of a combination of biomarker to be more accurately approached by
non-linear models. However, such models lead to optimization problems that are
far more computationally expensive to solve.
3.4 Multi-task extensions
Multi-task setting The assumption that there are benefits to be gained from
jointly learning on related tasks has long driven the fields of multi-task learning
and multi-task feature selection. This also holds for biomarker discovery [60,61]
For example, in toxicogenomics, where one studies the response of a population
of cell lines to exposure to various chemicals [62], one could try to perform
feature selection for each chemical separately, but jointly selecting features for
all chemicals reduces the features-to-sample ratio of the data. eQTL studies,
which try to identify the SNPs driving the expression level of various genes, also
fall within this setting [63].
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Multi-task regularized linear regression Many multi-task variants of the lasso
have been proposed [64,33], and can be extended in spirit to various structural
regularizers, such as Grace [65]. Assuming T tasks, each containing nt training
samples, and denoting by βt the m-dimensional vector of regression weights for
task t, the first of these approaches consists in solving the optimization problem
defined by Eq.(11). The penalty term used enforces that the regression weights
are both sparse and smooth across tasks.
arg min
β1,...,βt∈Rm
T∑
t=1
1
nt
nl∑
i=1
(Xiβt − yi)2 + λ
T∑
t=1
||βt||2 . (11)
When a network structure is known over the phenotypes, the graph-fused
Lasso can be used to smooth coefficients across tasks [66]. One could imagine
combining this approach with a graph regularizer over the features. Although
this has not been done with the graph-fused Lasso, the authors of [67] successfully
used Laplacian-based regularizers both on the biomarkers and on the phenotypes
to analyze associations between DNA methylation (about 15, 000 CpG probes)
and gene expression. In related work, the authors of [68] use a Laplacian-based
penalty to discover the structure of the correlation between the traits.
Most of the multi-task approaches that have been proposed for regularized
regression assume that the same features should be selected across all tasks. In-
deed, while the multi-task lasso of [64] allows for different regression weights for
the selected features, it imposes that the same features have non-zero weights
across all tasks. While this is reasonable for some application domains, this as-
sumption is violated in a number of biomarker discovery settings. For instance,
lung diseases such as asthma and chronic obstructive pulmonary disease may
be linked to a set of common mutations, but there is no indication that the
exact same mutations are causal in both diseases. One way to address this
problem is to decompose the regression weights in two components, one that
is common to both tasks and one that is task specific, but this increases the
computational complexity and is not yet amenable to hundreds of thousands of
biomarkers [69,70].
Moreover, to the best of our knowledge, none of the multi-task regularized
regression methods that incorporate structured regularizers make it possible to
consider different structural constraints for different tasks. However, we may for
example want to consider different biological pathways for different diseases.
Multi-task penalized relevance Because of the computational efficiency of graph-
cut implementations, SConES can be extended to the multi-task setting in such
a way as to address these issues. Multi-SConES [65] proposes a multi-task feature
selection coupled with multiple network regularizers to improve feature selection
in each task by combining and solving multiple tasks simultaneously.
The formulation of Multi-SConES is obtained by the addition of a regularizer
across tasks. Assuming again T tasks, and denoting by 4 the symmetric differ-
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ence between two sets, this formulation is given by Eq.(12).
arg max
S1,...,ST⊆V
T∑
t=1
∑
p∈St
R({p})− η|St| − λ
∑
p∈St
∑
q/∈St
Wpq
− µ∑
t<u
|Su 4Sv|. (12)
Limitations The main challenges of current multi-task approaches for biomarker
discoveries are linked to their computational complexity, which grows at best lin-
early with the number of tasks. Allowing different features to be selected across
tasks, imposing different network constraints for different tasks, and leveraging
prior knowledge on the correlation structure between tasks all increase the com-
putational complexity of the model, which currently limits the applicability of
existing methods to a handful of tasks at most.
4 Open Problems
The three main challenges in network-guided biomarker discovery today are: de-
parting from linear models; guaranteeing stability; and evaluating the statistical
significance of the detected modules.
Problem 1. There is no method that incorporates network information
and accounts for non-linear effects between genetic loci. Non-additive
epistatic effects are believed to play an important role in a number of human
diseases, such as breast cancer [71], ovarian cancer [72], hypertension [73], or
type-2 diabetes [74].
A large number of methods, reviewed in [75], have been proposed to perform
exhaustive association tests between pairs of SNPs and a phenotype. A first step
to address the lack of approaches relying on biological networks for the detec-
tion of non-linear interaction effects between SNPs and a phenotype would be
to combine them with the approaches outlined above; the penalized relevance
framework lends itself particularly well to this. However, this is still limited to
interactions between two loci, but more might be at play, and models for higher-
order interactions are required.
Embedded approaches for feature selection are not limited to linear algorithms.
Several promising approaches have been proposed in recent years along those
lines, based mostly on random forets [76,77], but also on Bayesian neural net-
works [78].
Alternatively, Drouin et al. [79] propose to use set covering machines [80] to learn
conjunctions of disjunctions of short genomic sequences to predict bacterial re-
sistance to antibiotics. Unlike random-forests-based approaches, this approach
only consider specific types of biomarkers interactions (combinations of logical
ANDs and ORs on their presence/absence), but it also has the potential to un-
cover epistatic interactions not detectable with the usual quadratic methods.
However, to the best of our knowledge, no approach exist that allows for the
integration of prior knowledge as networks in these higher-order, non-linear in-
teraction models, and this would be an exciting research avenue to pursue.
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Problem 2. There is no method to guarantee stable feature selection.
The stability (or robustness) of feature selection procedures, meaning their abil-
ity to retain the same features upon minor perturbations of the data, remains a
major predicament in the high-dimensional, low sample-size setting. Current al-
gorithms typically yield widely different results for different subsets of the same
set of samples [51]. This high variability implies that they capture idiosyncrasies
rather than truly relevant features. This casts doubts on the reliability of pre-
dictive algorithms built on the selected features and impedes interpreting these
features to yield novel biological insights. However, this question has only re-
cently started to come under investigation [81].
Most of the work in that domain has tried to yield lower-dimensional represen-
tations by grouping features together in meta-features, based either on the data
or on prior knowledge [82,83]. Unfortunately, these groupings, if done wrongly,
can confuse the feature selection procedure even more.
Alternatively, ensemble approaches are based upon the idea of ensemble learning
methods to combine the strengths of multiple weak learners to form a stronger
predictor. Bagging approaches, in which each of the selector is based on a sub-
sample of the data, have been shown to be consistent in settings in which the
procedure based on the full data was not [84,85].
Finally, variable-reduction approaches have led to schemes which reweight sam-
ples based on their suitability for the estimation of feature importance [86].
However, all these efforts are in their infancy and ranking features based on
t-test scores often still yields the most stable selection in practice [52,53].
Problem 3. There is no method to assess the statistical significance
of the uncovered modules. Very few methods can determine the statistical
significance of the association between multiple biomarkers and a phenotype,
despite it being key to the interpretation of biomarker discovery outcomes. A
recent paper [87] proposes to do this for intervals of the genome. The extension
of this work to network modules, however, is not trivial.
Work on confidence intervals on edge differences between brain imaging net-
works [88] solve a related problem. However, in the case of network-guided
biomarker discovery, one is interested in evaluating the significance of node (and
not edge) differences, and it is not obvious whether biological networks can be
described with similar models as brain images.
5 Future Outlook
We can hardly hope to understand the biology underlying complex diseases
without considering the molecular interactions that govern entire cells, tissues
or organisms. The approaches we discussed offer a principled way to perform
biomarker discovery in a systems biology framework, by integrating knowledge
accumulated in the form of interaction networks into studies associating genomic
features with a disease or response to treatment. While these methods are still
in their infancy, in strong part because of the statistical and computational
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challenges outlined in Section 4, we believe that they can become powerful tools
in the realization of precision medicine.
Future research directions for biomarker discovery include the development
of (1) machine learning approaches for stable, non-linear, multi-task feature se-
lection; (2) statistical techniques for the evaluation of the significance of the
association detected by complex models; and (3) the refinement and choice
of appropriate network data. While most network-guided biomarker discovery
studies make use of generic gene-gene interaction networks such as STRING or
BioGRID, many other possibilities are starting to open up. They include disease-
specific networks such as ACSN, but we can also imagine using for example eQTL
networks based on previous studies [89], or three-dimensional chromatin inter-
action networks [90]. Methods that integrate these multiple types of networks
may be needed; that the regularized regression or penalized relevance methods
we discussed can all accomodate weighted networks (either directly or through
simple modifications) will facilitate these developments.
Finally, serious progress in the field of biomarker discovery requires proper
validation, at the very least in other data sets pertaining to the same trait,
of the pertinence of the modules identified by these various methods. Because
this requires that modelers convince the owners of such data sets to run exper-
iments to this end, this is often hard to implement outside of large consortium
collaborations, and a major limitation of most of the work cited in this chapter.
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